Calcium-dependent regulation of Rho and myosin phosphatase in vascular smooth muscle

Biomedical Reviews

Volumn 16, Issue , 2005, Pages 13-21

  Takuwa, Yoh ^a,b   Yoshioka, Kazuaki ^a   Takuwa, Noriko ^a   Wang, Yu ^a   Azam, Mohammed Ali ^a   Sugimoto, Naotoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Contraction; Myosin light chain phosphorylation; MYPT1; Phosphoinositide 3 kinase class II ; Rho kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CALCIUM; MYOSIN LIGHT CHAIN KINASE; MYOSIN PHOSPHATASE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; RHO FACTOR; RHO KINASE; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; DEPOLARIZATION; ENZYME ACTIVATION; ENZYME INHIBITION; PHOSPHORYLATION; VASCULAR SMOOTH MUSCLE;

EID: 33845918543     PISSN: 1310392X     EISSN: None     Source Type: Journal    
DOI: 10.14748/bmr.v16.91     Document Type: Article

References (39)

1. Rasmussen H, Takuwa Y, Park S. Protein kinase C in the regulation of smooth muscle contraction. FASEB J 1987; 1: 177-185.
2. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994; 372: 231-236.
3. Takuwa Y. Regulation of vascular smooth muscle contraction. The roles of Ca2+, protein kinase C and myosin light chain phosphatase. Jpn Heart J 1996; 37: 793-813.
4. Hartshorne DJ, Ito M, Ikebe M. Myosin and contractile activity in smooth muscle. Adv Exp Med Biol 1989; 255: 269-277.
5. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003; 83: 1325-1358.
6. Hartshorne DJ, Ito M, Erdodi F. Role of protein phosphatase type I in contractile functions: myosin phosphatase. J Biol Chem 2004; 279: 37211-37214.
7. Alessi L, Macdougall K, Sola M, Ikebe M, Cohen P. The control of protein phosphatase-1 by targeting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein phosphatase-1. Eur J Biochem 1992; 210: 1023-1035.
8. Noda M, Yasuda-Fukazawa C, Moriishi K, Kato T, Okuda T, Kurokawa K, et al. Involvement of Rho in GTPγS-induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: inhibition of phosphatase activity. FEBS Lett 1995; 367: 246-250.
9. Aelst LV, Souza-Schorey CD. Rho GTPases and signaling networks. Genes Dev 1997; 11: 2295-2322.
10. Gohla A, Schlutz G, Offermanns S. Role for 612/13 in agonist-induced vascular smooth muscle cell contraction. Circ Res 2000; 87: 221-227.
11. 2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Circ Res 2003; 93: 548-556.
12. 2+ sensitization of smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 1991; 266: 1708-1715.
13. Kitazawa T, Masuo M, Somlyo AP. G Protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc Natl Acad Sci USA 1991; 88: 9307-9310.
14. Hirata K, Kikuchi A, Sasaki S, Kuroda S, Kaibuchi K, Matsuura Y, et al. Involvement of rho p21 in the GTPγS-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem 1992; 267: 8719-8722.
15. Nagumo H, Sasaki Y, Ono Y, Okamoto H, Seto M, Takuwa Y. Rho kinase inhibitor HA1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. Am J Physiol 2000; 278: C57-C65.
16. Narumiya S, Ishizaki T, Watanabe N. Rho effectors and reorganization of actin cytoskeleton. FEBS Lett 1997; 410: 68-72.
17. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996; 273: 245-248.
18. Feng J, Ito M, Ichikawa K, Nishikawa M, Hartshorne DJ, Nakano T. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem 1999; 274: 37385-37390.
19. Velasco G, Armstrong C, Morrice N, Frame S, Cohen P. Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1M at Thr850 induces its dissociation from myosin. FEBS Lett 2002; 527: 101-104.
20. 2+ sensitization in rabbit smooth muscle. J Physiol 2003; 546: 879-889.
21. Niiro N, Koga Y, Ikebe M. Agonist-induced changes in the phosphorylation of the myosin-targeting subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle. Biochem J 2003; 369: 117-128.
22. MacDonald JA, Borman MA, Muranyi A, Somlyo AV, Hartshorne DJ, Haystead TAJ. Identification of the endogenous smooth muscle myosin phosphatase- associated kinase. Proc Natl Acad Sci USA 2001; 98: 2419-2424.
23. Muranyi JA, MacDonald JT, Deng DP, Wilson TA, Haystead J, Walsh MP, et al. Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase. Biochem J 2002; 366: 211-216.
24. Eto M, Ohmori T, Suzuki M, Furuya K, Morita F. A noved protein phosphatase1 inhibitory protein potentiated by protein kinase C isolated from porcine aorta media and characterization. J Biochem 1995; 118: 1104-1107.
25. Kitazawa T, Eto M, Woodsome TP, Brautigan DL. Agonist trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 2000; 275: 9897-9900.
26. MacDonald JA, Eto M, Borman MA, Brautigan DL, Haystead TAJ. Dual Ser and Thr phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by MYPT-associated kinase. FEBS Lett 2001; 493: 91-94.
27. Sakurada S, Okamoto H, Takuwa N, Sugimoto N, Takuwa Y. Rho activation in excitatory agonist-stimulated vascular smooth muscle. Am J Physiol 2001; 281: C571-C578.
28. Bishop L, Hall A. Rho GTPase and their effector proteins. Biochem J 2000; 348: 241-255.
29. 13 in receptor-mediated stress fiber formation. J Biol Chem 1999; 274: 17901-17907.
30. Booden MA, Siderovski DP, Der CJ. Leukemia-associated Rho guanine nucleotide exchange factor promotes Gαq-coupled activation of RhoA. Mol Cell Biol 2002; 22: 4053-4061.
31. Chikumi H, Vazquez-Prado J, Servitja J-M, Miyazaki H, Gutkind JS. Potent activation of RhoA by Gαq and Gαq-coupled receptors. J Biol Chem 2002; 277: 27130-27134.
32. 2+ concenyration in rabbit aorta using the photoprotein, aequorin. Effect of atrial natriuretic peptide on agonist-induced Ca2+ signal generation. J Clin Invest 1987; 80: 248-257.
33. 2+ sensitivity in rabbit pulmonary artery smooth muscle. Pflugers Arch 1990; 417: 21-8.
34. Wang Y, Yoshioka K, Azam MA, Takuwa N, Sakurada S, Kayaba Y, et al. Class II phosphoinositide 3-kinase alfa-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle. Biochem J 2006; doi: 10.1042/BJ20051471; (in press).
35. Stein RC, Waterfield MD. PI3-kinase inhibition: a target for drug development? Mol Med Today 2000; 6: 347-357.
36. Rameh LE, Cantley LC. The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem 1999; 274: 8347-8350.
37. Domin J, Pages F, Volinia S, Rittenhouse SE, Zvelebil MJ, Stein RC, et al. Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin. Biochem J 1997; 326: 139-47.
38. Hayashi K, Takahashi M, Nishida W, Yoshida K, Ohkawa Y, Kitabatake A, et al. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ Res 2001; 89: 251-258.
39. Thorneloe KS, Nelson MT. Ion channels in smooth muscle: regulators of intracellular calcium and contractility. Can J Physiol Pharmacol 2005; 83: 215-42.